Protara Therapeutics
€4.3
20
+€0.02+0.47% Thursday 15:07
Statistics
Day High
4.1
Day Low
4.1
52W High
6.5
52W Low
2.26
Volume
-
Avg. Volume
-
Mkt Cap
165.92M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
30AprExpected
Expected EPS
-0.348571
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-84.65MNet Income
Analyst Ratings
$18.72Average Price Target
The highest estimate is 20.49.
From 3 ratings within the last 6 months. This is not an investment recommendation.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow 1KPA.F. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap148.78B
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Merck
MRK
Mkt Cap214.76B
AMGEN
AMGN
Mkt Cap160.66B
Pfizer
PFE
Mkt Cap140.15B
Novartis
NVS
Mkt Cap237.61B
Abbvie
ABBV
Mkt Cap385.18B
Roche
RHHBY
Mkt Cap258.9B
Astrazeneca
AZN
Mkt Cap256.58B
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
About
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York.
Show more...
CEO
Mr. Jesse Shefferman
Employees
28
Country
US
ISIN
US74365U1079
WKN
000A2P4JE
Listings
0 Comments
Share your thoughts
FAQ
What is Protara Therapeutics stock price today?▼
The current price of 1KPA.F is €4.3 EUR — it has increased by +0.47% in the past 24 hours. Watch Protara Therapeutics stock price performance more closely on the chart.
What is Protara Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Protara Therapeutics stocks are traded under the ticker 1KPA.F.
Is Protara Therapeutics stock price growing?▼
1KPA.F stock has fallen by -0.46% compared to the previous week, the month change is a -17.31% fall, over the last year Protara Therapeutics has showed a +17.49% increase.
What is Protara Therapeutics market cap?▼
Today Protara Therapeutics has the market capitalization of 165.92M
When is the next Protara Therapeutics earnings date?▼
Protara Therapeutics is going to release the next earnings report on April 30, 2026.
What were Protara Therapeutics earnings last quarter?▼
1KPA.F earnings for the last quarter are -0.32 EUR per share, whereas the estimation was -0.27 EUR resulting in a -18.81% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Protara Therapeutics revenue for the last year?▼
Protara Therapeutics revenue for the last year amounts to 0 EUR.
What is Protara Therapeutics net income for the last year?▼
1KPA.F net income for the last year is -84.65M EUR.
How many employees does Protara Therapeutics have?▼
As of April 04, 2026, the company has 28 employees.
In which sector is Protara Therapeutics located?▼
Protara Therapeutics operates in the Health Care sector.
When did Protara Therapeutics complete a stock split?▼
The last stock split for Protara Therapeutics was on January 10, 2020 with a ratio of 1:40.
Where is Protara Therapeutics headquartered?▼
Protara Therapeutics is headquartered in New York, US.